References
- Chantzi FM, Papadopoulos NG, Bairamis T, Tsiakou M, Bournousouzis N, Constantopoulos AG, et al. Human rhinoviruses in otitis media with effusion. Pediatr Allergy Immunol 2006; 17: 514–18
- Hurst DS, Venge P. The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg 1993; 108: 711–22
- Iino Y, Nagamine H, Yabe T, Matsutani S. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 2001; 31: 1135–43
- Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T. Clinical characteristics of so-called eosinophilic otitis media. Auris Nasus Larynx 2002; 29: 19–28
- Sobol SE, Taha R, Schloss MD, Mazer BD, Manoukian JJ, Tewfik TL, et al. TH2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol 2002; 110: 125–30
- Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, et al. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol 2003; 123: 383–7
- Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036–42
- Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003; 111: 520–6
- Vancheri C, Ohtoshi T, Cox G, Xaubet A, Abrams JS, Gauldie J, et al. Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991; 4: 11–17
- Flolkerts G, Busse W, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998; 157: 1708–20
- Wright ED, Hurst D, Miotto D, Giguere C, Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5 (IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg 2000; 123: 533–8
- Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003; 16: 637–46
- Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55: 255–81
- Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732–8
- Xatzipsalti M, Kyrana S, Tsolia M, Psarras S, Bossios A, Laza-Stanca V, et al. Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med 2005; 172: 1037–40
- Papadopoulos NG, Papi A, Psarras S, Johnston SL. Mechanism of rhinovirus-induced asthma. Pediatr Respir Rev 2004; 5: 255–60
- Ghildyal R, Dagher H, Howard D, de Silva D, Li X, Freezer NJ, et al. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol 2005; 75: 608–15
- Elias JA, Wu Y, Zheng T, Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 1997; 273: L648–55
- Takahashi N, Yamada T, Narita N, Fujieda S. Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin Immunol 2006; 118: 51–8
- Oliver BG, Johnston SL, Baraket M, Burgess JK, King NJ, Roth M, et al. Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 2006; 7: 71
- Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937–47
- Xatzipsalti M, Kyrana S, Tsolia M, Psarras S, Bossios A, Laza-Stanca V, et al. Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med 2005; 172: 1037–40
- Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 1999; 29: 2684–94
- Fukumoto A, Nonaka M, Ogihara N, Pawankar R. Induction of TARC production by lipopolysaccharide and interleukin-4 in nasal fibroblasts. Int Arch Allergy Immunol 2007; 145: 291–7